[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Chen, W., Zhang, W., Wu, R., et al. (2019) Identification of Biomarkers Associated with Histological Grade and Prognosis of Gastric Cancer by Co-Expression Network Analysis. Oncology Letters, 18, 5499-5507. https://doi.org/10.3892/ol.2019.10869
|
[3]
|
张迪, 何晶, 牛海文. 胃癌的治疗进展[J]. 新疆医学, 2021, 51(4): 464-467.
|
[4]
|
Machlowska, J., Baj, J., Sitarz, M., et al. (2020) Gastric Cancer: Epidemiology, Risk Factors. Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences, 21, Article 4012. https://doi.org/10.3390/ijms21114012
|
[5]
|
Shimada, H., Noie, T., Ohashi, M., et al. (2013) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systenatic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. https://doi.org/10.1007/s10120-013-0259-5
|
[6]
|
Figueiredo, C., Camargo, M.C., Leite, M., et al. (2017) Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. Current Topics in Microbiology and Immunology, 400, 277-304. https://doi.org/10.1007/978-3-319-50520-6_12
|
[7]
|
Yamamoto, M., Rashid, O.M. and Wong, J. (2015) Surgical Management of Gastric Cancer: The East vs. West Perspective. Journal of Gastrointestinal Oncology, 6, 79-88.
|
[8]
|
Yashiro, M. and Matsuoka, T. (2015) Sentinel Node Navigation Surgery for Gastric Cancer: Overview and Perspective. World Journal of Gastrointestinal Surgery, 7, 1-9. https://doi.org/10.4240/wjgs.v7.i1.1
|
[9]
|
Mclarnon, A. (2014) 2014 Gastrointestinal Cancers Symposium. The Lancet Oncology, 15, 262. https://doi.org/10.1016/S1470-2045(13)70340-1
|
[10]
|
Hudler, P. (2015) Challenges of Deciphering Gastric Cancer Heterogeneity. World Journal of Gastroenterology, 21, 10510-10527. https://doi.org/10.3748/wjg.v21.i37.10510
|
[11]
|
Marrelli, D., Polom, K., Pascale, V., et al. (2016) Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-Cardia Gastric Cancer. Annals of Surgical Oncology, 23, 943-950. https://doi.org/10.1245/s10434-015-4931-3
|
[12]
|
屈晓辉, 周建华. bFGF/FGFR信号转导途径与肿瘤[J]. 国际病理科学与临床杂志, 2007, 27(2): 125-129.
|
[13]
|
Katoh, M. and Katoh, M. (2006) FGF Signaling Network in the Gastrointestinal Tract (Review). International Journal of Oncology, 29, 163-168. https://doi.org/10.3892/ijo.29.1.163
|
[14]
|
Olsen, S.K., Garbi, M., Zampieri, N., et al. (2003) Fibroblast Growth Factor (FGF) Homologous Factors Share Structural but Not Functional Homology with FGFs. Journal of Biological Chemistry, 278, 34226-34236. https://doi.org/10.1074/jbc.M303183200
|
[15]
|
Razzaque, M.S. and Lanske, B. (2007) The Emerging Role of the Fibroblast Growth Factor-23-Klotho Axis in Renal Regulation of Phosphate Homeostasis. Journal of Endocrinology, 194, 1-10. https://doi.org/10.1677/JOE-07-0095
|
[16]
|
Beenken, A. and Mohammadi, M. (2009) The FGF Family: Biology, Pathophysiology and Therapy. Nature Reviews Drug Discovery, 8, 235-253. https://doi.org/10.1038/nrd2792
|
[17]
|
Revest, J.M., De Moerlooze, L. and Dickson, C. (2000) Fibroblast Growth Factor 9 Secretion Is Mediated by a Non-Cleaved Amino-Terminal Signal Sequence. Journal of Biological Chemistry, 275, 8083-8090. https://doi.org/10.1074/jbc.275.11.8083
|
[18]
|
Goetz, R., Beenken, A., Ibrahimi, O.A., et al. (2007) Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members. Molecular and Cellular Biology, 27, 3417-3428. https://doi.org/10.1128/MCB.02249-06
|
[19]
|
Hacker, U., Nybakken, K. and Perrimon, N. (2005) Heparan Sulphate Proteoglycans: The Sweet Side of Development. Nature Reviews Molecular Cell Biology, 6, 530-541. https://doi.org/10.1038/nrm1681
|
[20]
|
黄鼎智. 晚期胃癌靶向治疗进展[J]. 中国肿瘤临床, 2014, 41(1): 1408-1412.
|
[21]
|
Fok, J., Ramos-Montoya, A., Vazquez-Chantada, M., et al. (2019) AZD7648 Is a Potent and Selective DNA-PK Inhibitor That Enhances Radiation, Chemotherapy and Olaparib Activity. Nature Communications, 10, Article No. 5065. https://doi.org/10.1038/s41467-019-12836-9
|
[22]
|
Greulich, H. and Pollock, P.M. (2011) Targeting Mutant Fibroblast Growth Factor Receptors in Cancer. Trends in Molecular Medicine, 17, 283-292. https://doi.org/10.1016/j.molmed.2011.01.012
|
[23]
|
Oki, M., Yamamoto, H., Taniguchi, H., et al. (2008) Overexpression of the Receptor Tyrosine Kinase EphA4 in Human Gastric Cancers. World Journal of Gastroenterology, 14, 5650-5656. https://doi.org/10.3748/wjg.14.5650
|
[24]
|
Wen, D., Li, S., Ji, F., et al. (2013) miR-133b Acts as a Tumor Suppressor and Negatively Regulates FGFR1 in Gastric Cancer. Tumor Biology, 34, 793-803. https://doi.org/10.1007/s13277-012-0609-7
|
[25]
|
Xu, C., Li, W., Qiu, P., et al. (2015) The Herapeutic Potential of a Novel Non-ATP-Competitive Fibroblast Growth Factor Receptor 1 in Hibitor on Gastric Cancer. Anti-Cancer Drugs, 26, 379-387. https://doi.org/10.1097/CAD.0000000000000195
|
[26]
|
Schafer, M.H., Lingohr, P., Strasser, A., et al. (2015) Fibroblast Growth Factor Receptor 1 Gene Amplification in Gastric Adenocarcinoma. Human Pathology, 46, 1488-1495. https://doi.org/10.1016/j.humpath.2015.06.007
|
[27]
|
Katoh, M. (2008) Cancer Genomics and Genetics of FGFR2 (Review). International Journal of Oncology, 33, 233-237.
|
[28]
|
Qiu, H., Yashiro, M., Zhang, X., et al. (2011) A FGFR2 Inhibitor, Ki23057, Enhances the Chemosensitivity of Drug-Resistant Gastric Cancer Cells. Cancer Letters, 307, 47-52. https://doi.org/10.1016/j.canlet.2011.03.015
|
[29]
|
Yashiro, M., Shinto, O., Nakamura, K., et al. (2010) Synergistic Antitumor Effects of FGFR2 Inhibitor with 5-Fluorouracil on Scirrhous Gastric Carcinoma. International Journal of Cancer, 126, 1004-1016. https://doi.org/10.1002/ijc.24763
|
[30]
|
Sonvilla, G., Allerstorfer, S., Heinzle, C., et al. (2010) Fibroblast Growth Factor Receptor 3-IIIc Mediates Colorectal Cancer Growth and Migration. British Journal of Cancer, 102, 1145-1156. https://doi.org/10.1038/sj.bjc.6605596
|
[31]
|
钟键, 金正贤, 卞卫星, 等. 膀胱癌组织FGFR3基因突变和蛋白表达与预后关系研究[J]. 中华肿瘤防治杂志, 2020, 27(2): 130-135.
|